Anti-RBPJK antibody [EPR13479]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
4
(3 Reviews)
|
(18 Publications)
Rabbit Recombinant Monoclonal RBPJK antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Rat, Human samples. Cited in 18 publications.
View Alternative Names
IGKJRB, IGKJRB1, RBPJK, RBPSUH, RBPJ, Recombining binding protein suppressor of hairless, CBF-1, J kappa-recombination signal-binding protein, RBP-J kappa, Renal carcinoma antigen NY-REN-30, RBP-J, RBP-JK
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-RBPJK antibody [EPR13479] (AB180588)
Immunocytochemistry/ Immunofluorescence analysis of MG 63 (human osteosarcoma fibroblast) cells labeling RBPJK with Purified ab180588 at 1 : 50 dilution. Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1 : 200 dilution. Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed (ab150081) was used as the secondary antibody at 1 : 1000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control.
Confocal image showing mainly nuclear staining in MG-63 cell line(shown in green). The counterstain was observed in magenta. Nuclear DNA was labelled with DAPI (shown in blue).
Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8).
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-RBPJK antibody [EPR13479] (AB180588)
Flow cytometry overlay histogram of 4% Paraformaldehyde MG 63 (human osteosarcoma fibroblast) cells permeabilised with 90% methanol labelling RBPJK with ab180588 at 1/50 dilution (red) compared with a Rabbit monoclonal IgG (ab172730) (Black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150081) , at 1/5000 dilution was used as the secondary antibody.
- WB
Supplier Data
Western blot - Anti-RBPJK antibody [EPR13479] (AB180588)
All lanes:
Western blot - Anti-RBPJK antibody [EPR13479] (ab180588) at 1/2000 dilution
Lane 1:
293 cell line lysate
Lane 2:
MCF7 cell line lysate
Lane 3:
HeLa cell line lysate
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 56 kDa
Observed band size: 60 kDa
false
- WB
Lab
Western blot - Anti-RBPJK antibody [EPR13479] (AB180588)
Blocking/Diluting buffer and concentration 5% NFDM/TBST.
Extra band at : 90kDa
We are unsure as to the identity of this extra band.
For Lysate preparation protocol, please refer to the protocol section of the website and/or here.
All lanes:
Western blot - Anti-RBPJK antibody [EPR13479] (ab180588) at 1/1000 dilution
Lane 1:
MCF-7 (Human breast adenocarcinoma epithelial cell) whole cell lysate 20ug prepared using RIPA lysis method at 20 µg
Lane 2:
MCF-7 (Human breast adenocarcinoma epithelial cell) whole cell lysate 20ug prepared using 1% SDS hot lysis method at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/20000 dilution
Predicted band size: 56 kDa
Observed band size: 60 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-RBPJK antibody [EPR13479] (AB180588)
The double bands are consistent with what has been described in the literature PMID : 9102301 and 24603501
All lanes:
Western blot - Anti-RBPJK antibody [EPR13479] (ab180588) at 1/1000 dilution
Lane 1:
Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysates at 15 µg
Lane 2:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysates at 15 µg
Lane 3:
F9 (Mouse embryonal carcinoma epithelial cell) whole cell lysates at 15 µg
Lane 4:
C6 (Rat glial tumor glial cell) whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 56 kDa
Observed band size: 56-60 kDa
false
- WB
Lab
Western blot - Anti-RBPJK antibody [EPR13479] (AB180588)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RBPJK antibody [EPR13479] (ab180588)
Lane 1:
THP-1 (human monocytic leukemia monocyte) whole cell lysate at 20 µg
Lane 2:
MG-63 (human osteosarcoma fibroblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 55 kDa
false
Exposure time: 48s
- WB
Lab
Western blot - Anti-RBPJK antibody [EPR13479] (AB180588)
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : Lane 1-3 : 3 minutes
Lane 4 : 45 seconds
All lanes:
Western blot - Anti-RBPJK antibody [EPR13479] (ab180588) at 0.4 µg/mL
Lane 1:
C6 (Rat glial tumor glial cell) whole cell lysate at 20 µg
Lane 2:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 20 µg
Lane 3:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 4:
Raw264.7 (Mouse abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 56 kDa
false
Related conjugates and formulations (7)
-
Anti-RBPJK antibody [EPR13479] - BSA and Azide free
-
660 APC
APC Anti-RBPJK antibody [EPR13479]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-RBPJK antibody [EPR13479]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-RBPJK antibody [EPR13479]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-RBPJK antibody [EPR13479]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-RBPJK antibody [EPR13479]
-
578 PE
PE Anti-RBPJK antibody [EPR13479]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein functions as a central component of the Notch signaling complex. It interacts with other proteins to regulate the expression of genes that guide cell fate decisions. RBPJK forms complexes with Notch intracellular domain and Mastermind-like (MAML) co-activators and it can switch between repressor or activator of transcription depending on its binding partners. This regulation ensures proper development and tissue homeostasis.
Pathways
RBPJK influences processes that are critical in cell differentiation and proliferation. It resides within the Notch signaling pathway where it is essential for transmitting Notch receptor signals into the cell nucleus. RBPJK associates with proteins such as Notch1 and MAML1 facilitating a cascade of events important for determining cellular outcomes during developmental processes and maintaining stem cell populations.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
Molecular carcinogenesis 63:1449-1466 PubMed38801356
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:7676872 PubMed36238644
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:494 PubMed35610206
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 8:639476 PubMed35111821
2022
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:1754 PubMed35071448
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:19587 PubMed33177556
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 22:3759-3766 PubMed33000274
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of cell biology 219: PubMed32756905
2020
Applications
Unspecified application
Species
Unspecified reactive species
Neurorehabilitation and neural repair 34:640-651 PubMed32543269
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:372 PubMed32415085
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com